1. Mazzolari E, Forino C, Razza A, Porta F, Villa A, Notaran-gelo LD. A single-center experience in 20 patients with infantile malignant osteopetrosis. Am J Hematol. 2009; 84:473–9.
Article
2. Stark Z, Savarirayan R. Osteopetrosis. Orphanet I Rare Dis. 2009; 4:5.
Article
3. Siddaiahgari SR, Makadia D, Shah N, Devi RR, Lingappa L. Identification of novel mutation in autosomal recessive infantile malignant osteopetrosis. Indian I Pediatr. 2014; 81:969–70.
Article
4. Sobacchi C, Schulz A, Coxon FP, Villa A, Helfrich MH. Osteopetrosis: genetics, treatment and new insights into osteoclast function. Nat Rev Endocrinol. 2013. 9z522–36.
Article
5. Nyholm IL, Schleiss MR. Prevention of maternal cytomegalovirus infection: current status and future prospects. Int I Womens Health. 2010; 2:23–35.
6. Ihde LL, Forrester DM, Gottsegen CI, Masih S, Patel DB, Vachon LA, et al. Sclerosing bone dysplasias: review and differentiation from other causes of osteosclerosis. Radiographics. 2011; 31:1865–82.
Article
7. Albers-Schénberg HE. Réntgenbilder einer seltenen Kno-chenerkrankung. Munch Med Wochenschr. 1904; 51:365–8.
8. Superti-Furga A, Unger S. Nosology and classification of genetic skeletal disorders: 2006 revision. Am I Med Genet A. 2007. 143A21–18.
Article
9. Ornoy A, Diav-Citrin 0. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol. 2006; 21:399–409.
10. Pass RF, Fowler KB, Boppana SB, Britt WI, Stagno S. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. I Clin Virol. 2006; 35:216–20.
Article
11. Oliver SE, Cloud GA, Sanchez P], Demmler GJ, Dankner W, Shelton M, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegaloVirus infections involving the central nervous system. I Clin Virol. 2009; 46:522–6.
Article